Marked Up-Regulation of ACE2 in Hearts of Patients With Obstructive Hypertrophic Cardiomyopathy: Implications for SARS-CoV-2–Mediated COVID-19-Reference-Cited by-同舟云学术

Marked Up-Regulation of ACE2 in Hearts of Patients With Obstructive Hypertrophic Cardiomyopathy: Implications for SARS-CoV-2–Mediated COVID-19

Published:2020-07 Issue:7 Volume:95 Page:1354-1368
ISSN:0025-6196
Container-title:Mayo Clinic Proceedings
language:en
Short-container-title:Mayo Clinic Proceedings

Author:

Bos J. Martijn^ORCID,Hebl Virginia B.,Oberg Ann L.,Sun Zhifu,Herman Daniel S.,Teekakirikul Polakit,Seidman Jonathan G.^ORCID,Seidman Christine E.,dos Remedios Cristobal G.,Maleszewski Joseph J.,Schaff Hartzell V.,Dearani Joseph A.,Noseworthy Peter A.,Friedman Paul A.^ORCID,Ommen Steve R.,Brozovich Frank V.^ORCID,Ackerman Michael J.^ORCID

Funder

Mayo Clinic Windland Smith Rice Comprehensive Sudden Cardiac Death Program

Paul and Ruby Tsai and Family Hypertrophic Cardiomyopathy Research

National Institutes of Health

Howard Hughes Medical Institute

Publisher

Elsevier BV

Subject

General Medicine

Reference45 articles.

1. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults;Maron;Circulation,1995

2. Sudden death in young athletes;Maron;Circulation,1980